Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (symbol: HUM) is a leading private health insurer in the United States, with a primary focus on Medicare Advantage plans. The company has carved out a significant niche in the healthcare market by specializing in government-sponsored programs. Nearly all of Humana's medical memberships come from individual and group Medicare Advantage plans, Medicaid, and the military's Tricare program. This makes it a pivotal player in providing health insurance solutions to a diverse segment of the population.
In addition to its core insurance offerings, Humana is a frontrunner in stand-alone prescription drug plans, particularly for seniors enrolled in traditional fee-for-service Medicare. This is part of their broader commitment to ensuring comprehensive healthcare accessibility for all members.
Humana continuously strives to innovate and improve its services, recognizing that healthcare needs are dynamic and vary among individuals, families, and communities. The company's cultural foundation is deeply rooted in helping members achieve optimal health by delivering personalized and simplified healthcare experiences. Their array of services includes not only medical insurance but also primary-care services, at-home healthcare services, and pharmacy benefit management.
The company's recent achievements and current projects reflect its commitment to holistic health solutions. Through CenterWell, Humana provides the latest updates and resources aimed at helping people live their healthiest lives on their terms, whenever and wherever they need it.
Humana's employees are central to its mission. The company has built an organization of dynamic talent, whose experience and passion are focused on putting the customer first. This dedication is evident in their innovative approach to healthcare, which continuously adapts to meet evolving needs.
With its strong financial condition and strategic partnerships, Humana is well-positioned to continue its leadership in the healthcare industry. Whether you are an investor looking for reliable stock performance or a member seeking high-quality healthcare services, Humana remains a standout choice.
Humana Inc. (NYSE: HUM) has successfully completed a public offering of $3.0 billion in senior notes, consisting of three tranches: $1.5 billion due 2023, $750 million due 2027, and $750 million due 2032. The expected net proceeds are approximately $2.973 billion. These funds will primarily support the $5.7 billion acquisition of Kindred at Home. If the acquisition is not finalized by January 22, 2022, the company will redeem the 2023 notes. The press release includes cautionary forward-looking statements regarding potential risks affecting business performance.
Humana Inc (NYSE: HUM) has appointed Sue Schick as President of its Group, Military, and Specialty businesses, effective September 1, 2021. Schick, who joined Humana in 2020 and has over 30 years of industry experience, succeeds Chris Hunter, who leaves to pursue other opportunities. Humana aims for ambitious growth in these segments. Currently, the Group, Military, and Specialty business serves 1.2 million employer group members and 12 million Commercial and Medicare Specialty members, while also administering the TRICARE health program for six million U.S. military beneficiaries.
Humana Inc. (NYSE: HUM) has announced a public offering of $3.0 billion in senior notes, comprising $1.5 billion of 0.650% notes due 2023, $750 million of 1.350% notes due 2027, and $750 million of 2.150% notes due 2032. The net proceeds, approximately $2.973 billion, will be used for the acquisition of Kindred at Home, which amounts to about $5.7 billion, inclusive of $1.9 billion in debt assumption. The offerings are scheduled to close on August 3, 2021, and are not conditioned on the acquisition's completion.
Humana reported its 2Q21 results, with GAAP revenue at $20.645 billion, a year-over-year increase from $19.083 billion in 2Q20. However, GAAP pretax income dropped significantly from $2.586 billion in 2Q20 to $738 million in 2Q21. The diluted EPS fell to $4.55 from $13.75, while the non-GAAP adjusted EPS was $6.89, down from $12.56. Despite challenges from the ongoing pandemic, the company revised its FY2021 GAAP EPS guidance to $24.97-$25.47 and maintained its adjusted EPS guidance of $21.25-$21.75. A substantial gain from the acquisition of Kindred at Home is expected, estimated at $1 billion.
XSOLIS has partnered with Humana to implement a real-time predictive analytics platform aimed at enhancing utilization review processes. This collaboration will integrate XSOLIS' CORTEX platform, which analyzes patient data from electronic medical records to streamline interactions between payers and providers. The Precision Utilization Management initiative will allow for 'touchless' status determinations, freeing up clinician time for patient care. Both companies aim to revolutionize medical necessity determinations and improve healthcare efficiency.
The Humana Foundation is awarding $1.7 million to nonprofit organizations in Louisville through its Community Partners Program, aimed at enhancing health equity. Since 2018, the program has distributed over $8 million to local nonprofits tackling social determinants of health. The 2021 funding focuses on small, BIPOC-led organizations addressing issues like food security, education, and access to care. Organizations awarded funding range from $50,000 to $250,000, with a deadline for additional applications set for July 23.
Humana Inc. (NYSE: HUM) has announced plans to hire up to 200 virtual, seasonal Enrollment Representatives in San Antonio, Texas. This initiative aligns with the Medicare Advantage and Prescription Drug Plan open enrollment period from Oct. 15 to Dec. 7, 2021. Seasonal roles can lead to full-time opportunities and offer competitive compensation with potential retention bonuses of up to $1,000. Applications are now open online, and candidates are encouraged to have customer service experience and proficiency in Microsoft Office.
Humana Inc. (NYSE: HUM) has entered into a multi-year agreement with Montefiore Health System, effective July 1. This partnership enables Humana's Medicare Advantage members to access Montefiore's extensive network, including 10 hospitals and over 200 outpatient sites, supported by approximately 4,000 physicians and 5,450 nurses across the Bronx, Westchester, and Hudson Valley. This collaboration aims to enhance healthcare access and improve the well-being of the Medicare population, aligning with both organizations' commitment to community health and quality care.
Humana Inc. (NYSE: HUM) is hiring up to 200 seasonal Enrollment Representatives in the Louisville area as part of its Medicare Advantage and Prescription Drug Plan open enrollment, which runs from Oct. 15 to Dec. 7, 2021. These positions, lasting six months or less, will be home-based for applicants living within a 50-mile radius of Louisville. Competitive compensation includes an hourly rate and a retention bonus of up to $1000. Virtual interviews will start this month, with positions beginning between late August and October. Humana collaborates with community organizations for recruitment.